Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and (Q73368715)
scientific article published on 01 May 1997
Language:
(P31) (Q13442814)
(P50) (Q56826661)
(Q37829946)
(P304) 2090-2096
(P407) (Q1860)
(P433) 5
(P478) 15
(P577) Thursday, May 1, 1997
(P921) (Q47912)
(P1433) (Q400292)
(P1476) "Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group" (language: en)
(P2093) A Ardizzoni
H Hansen
P Dombernowsky
T Gamucci
S Kaplan
B Schaefer
J Wanders
J Verweij
other details
description scientific article published on 01 May 1997

External Links